Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight
 (20min delay)
|
|||||
|
Last
31.3¢ |
Change
-0.003(0.79%) |
Mkt cap ! $124.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 31.0¢ | $105.8K | 336.7K |
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 65002 | 31.0¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 38723 | 9 |
| Last trade - 14.39pm 11/08/2025 (20 minute delay) ? |
|
|||||
|
Last
31.0¢ |
Change
-0.003 ( 3.13 %) |
||||
| Open | High | Low | Volume | ||
| 31.5¢ | 32.3¢ | 31.0¢ | 248071 | ||
| Last updated 14.57pm 11/08/2025 ? | |||||
| PAR (ASX) Chart |
